Quick Answer
CANNAPHARMARX, INC. reported Stockholders Equity of -$30.15 million for fiscal year 2025.
CANNAPHARMARX, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$30.15M | -52.2% |
| 2024 | -$19.81M | -63.0% |
| 2023 | -$12.15M | -170.1% |
| 2022 | $17.34M | +234.2% |
| 2021 | -$12.93M | -46.9% |
| 2020 | -$8.80M | -281.3% |
| 2019 | $4.85M | +1795.5% |
| 2018 | -$286.3K | +70.3% |
| 2017 | -$964.3K | -0.7% |
| 2016 | -$957.7K | -39.9% |
| 2015 | -$684.5K | -137.5% |
| 2014 | -$288.2K | +1.3% |
| 2013 | -$292.0K | -47.8% |
| 2012 | -$197.6K | -98.5% |
| 2011 | -$99.6K | -99661.0% |
| 2010 | $100.00 | +100.0% |
| 2009 | -$576.3K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$22.52M | -35.8% | +0.3% |
| June 30, 2025 | -$22.57M | -35.4% | -10.1% |
| March 31, 2025 | -$20.51M | +12.8% | -3.5% |
| December 31, 2024 | -$19.81M | -63.0% | -19.4% |
| September 30, 2024 | -$16.58M | +19.6% | +0.5% |
| June 30, 2024 | -$16.67M | +17.3% | +29.2% |
| March 31, 2024 | -$23.53M | -29.2% | -93.6% |
| December 31, 2023 | -$12.15M | +29.9% | +41.1% |
- CANNAPHARMARX, INC. showed a decrease of -52.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2009–2025 period, CANNAPHARMARX, INC.’s stockholders equity has declined by 5132.3% (from -$576.3 thousand to -$30.15 million).
- The most recent figure is from CANNAPHARMARX, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: